Company: NCEL
Filing Date: 2025-10-17
Form Type: POS AM
Source: 0001213900-25-099986
Chunk: 73

Company: NewcelX Ltd.
Filing Date: 2025-10-17
Form: POS AM
Chunk 73
---
          |  1.43 |     |             |
| Balance outstanding and exercisable at June 30, 2025 |     | 3,381,241 |   |     | $        |  8.38 |     |        3.00 |

The intrinsic value of exercisable but unexercised in -the-moneycommon share warrants at June 30, 2025 was $ 5,188,448. Option Plan On December 14, 2021, the Board of Directors adopted the Share Option Plan Regulation 2021 (the “Option Plan”). The purpose of the Option Plan is to retain, attract and motivate management, employees, directors and consultants by providing them with options to purchase common shares. The Board of Directors allocated fifteen percent ( 15%) of the Company’s fully diluted shares to awards that may be made pursuant to the Option Plan. The exercise prices, vesting and other restrictions of the awards to be granted under the Option Plan are determined by the Board of Directors, except that no share option may be issued with an exercise price less than the fair market value of the common shares at the date of the grant or have a term in excess of tenyears. Options granted under the Option Plan are exercisable in whole or in part at any time subsequent to vesting.

The following table summarizes total share option activity for the six-month period ended June 30, 2025:

|                                |     | Number of 
   Options |     | Weighted 
 Average  
 Exercise 
 Price    |       |
|:-------------------------------|:----|----------:|:----|:---------|------:|
| Balance at December 31, 2024   |     |    34,417 |     | $        | 47.14 |
| Granted                        |     |         — |     |          |     — |
| Exercised                      |     |         — |     |          |     — |
| Expired/cancelled              |     |         — |     |          |     — |
| Balance at June 30, 2025       |     |    34,417 |     | $        | 47.14 |
| Options vested and exercisable |     |    24,164 |     |          |       |

The weighted average remaining contractual life of each of the options outstanding, options vested and exercisable and options expected to vest at June 30, 2025 was 7.1years.

Annex A